MyFinsight
Home
Blog
About
Net loss
attributable to immunitybio...
-$230,378K
(-148.91%↓ Y/Y)
Net loss
attributable to...
-$12K
(36.84%↑ Y/Y)
Net loss
-$230,390K
(-148.87%↓ Y/Y)
Loss before income
taxes and...
-$230,390K
(-149.60%↓ Y/Y)
Product
$50,672K
(91.79%↑ Y/Y)
Product And Service
Other
$568K
(14100.00%↑ Y/Y)
Total other expense,
net
-$168,693K
(-702.54%↓ Y/Y)
Loss from operations
-$61,697K
(13.45%↑ Y/Y)
Interest and investment
income, net
$3,155K
(173.63%↑ Y/Y)
Total revenue
$51,240K
(93.91%↑ Y/Y)
Other income
(expense), net
$242K
(187.05%↑ Y/Y)
Change in fair value of
related-party convertible...
-$95,964K
(-8309.07%↓ Y/Y)
Change in fair value of
warrant liabilities
$44,190K
(1236.28%↑ Y/Y)
Interest expense related
to revenue...
$17,192K
(28.25%↑ Y/Y)
Interest
expense-Related Party
$14,032K
(-9.32%↓ Y/Y)
Total operating costs
and expenses
$112,937K
(15.58%↑ Y/Y)
Change in fair value of
derivative liabilities
-$692K
(-135.84%↓ Y/Y)
Interest
expense-Nonrelated Party
$20K
(300.00%↑ Y/Y)
Research and
development-Nonrelated Party
$57,690K
(10.03%↑ Y/Y)
Selling, general and
administrative-Nonrelated Party
$50,626K
(20.94%↑ Y/Y)
Research and
development-Related Party
$3,126K
(11.40%↑ Y/Y)
Selling, general and
administrative-Related Party
$1,197K
(151.47%↑ Y/Y)
Cost of sales
$298K
(119.12%↑ Y/Y)
Back
Back
Income Statement
ImmunityBio-logo-inverted-svg-svg
ImmunityBio, Inc. (IBRX)
ImmunityBio-logo-inverted-svg-svg
source: myfinsight.com
ImmunityBio, Inc. (IBRX)